Vimarsana
Biggest News Aggregation in the World

Page 3 - Pfizer Limited News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Limited Today - Breaking & Trending Today

Pfizer Ltd reports net profit of Rs. 150.66 crores in Q3 FY2023 - Vimarsana News

Pfizer Ltd reports net profit of Rs. 150.66 crores in Q3 FY2023

The Board of Directors of Pfizer Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.

Related Topics:
Pfizer LtdPfizer Limited
Reliance Industries tops charts on Wizikey Newsmaker Ranking - Vimarsana News

Reliance Industries tops charts on Wizikey Newsmaker Ranking

Reliance Industries Ltd, India's largest corporate by revenues, profits, and market value, topped the 2022 Wizikey Newsmaker report as India's most-visible corporate in the media.State Bank of India (SBI), ICICI Bank Limited, Bharti Airtel ...

Mukesh Ambani's Reliance Industries ranked India's most visible corporate firm - Vimarsana News

Mukesh Ambani's Reliance Industries ranked India's most visible corporate firm

Wizikey's, AI and ML technology gathers media intelligence from over 50 million news articles across 400,000+ online publications.

Oncology, digital health startups to receive Rs 65 lakh grant under Pfizer's INDovation Programme - Vimarsana News

Oncology, digital health startups to receive Rs 65 lakh grant under Pfizer's INDovation Programme

To accelerate the lab-to-market journey of the 6 winning startups

Spotlight: competition law in the pharmaceutical sector in United Kingdom - Vimarsana News

Spotlight: competition law in the pharmaceutical sector in United Kingdom

This article reviews the application of competition law principles to the pharmaceutical sector in United Kingdom, with particular regard to the merger control regime and anticompetitive behaviour.